How Should a Corporation Defend against False Claims Act Liability?

A claim is false if it contains a material misstatement or omission of fact. Materiality does not mean the government would have paid nothing; rather, it means the false statement or concealment had a natural tendency to influence or was capable of influencing a payment decision. Knowledge includes actual knowledge, deliberate ignorance, and reckless disregard. Courts analyze whether corporate policies, training, and supervision created conditions under which false claims were submitted despite available safeguards.

A qui tam action is a civil suit filed by a private citizen (the relator) on behalf of the United States. The relator can proceed under seal, allowing investigation before public disclosure. If the government declines to intervene and the relator proceeds alone, the relator bears litigation risk but retains a larger recovery share. If the government intervenes, it controls the litigation strategy. Both paths expose the corporation to the same substantive liability standards and damage formulas, but the procedural posture and settlement dynamics differ significantly.

A corporation that follows explicit government guidance or operates under an approved compliance program may argue good faith reliance, though this defense is fact-intensive and does not guarantee immunity. Courts examine whether the guidance was clear, whether the corporation reasonably interpreted it, and whether the corporation disclosed any ambiguity to the government. Documentation of the corporation's compliance efforts, training records, and internal controls becomes critical evidence in demonstrating good faith.

Cases brought under the False Claims Act are typically filed in federal court, including the Southern District of New York, which handles a high volume of government contract and healthcare fraud matters. Early motion practice in SDNY often focuses on whether the relator has pleaded sufficient factual allegations to survive dismissal under federal pleading standards. Corporations should prioritize complete and contemporaneous documentation of compliance decisions, regulatory submissions, and communications with government agencies, as delayed or incomplete records can hinder defense at summary judgment or trial. In practice, courts in this venue scrutinize the adequacy of internal controls and whether senior management was aware of or deliberately ignored red flags.

Corporations reduce False Claims Act risk through robust compliance programs that include clear policies, regular training, internal audit mechanisms, and whistleblower protection procedures. A well-documented compliance infrastructure demonstrates good faith and may support a materiality or knowledge defense. When a corporation discovers potential false claims, prompt disclosure to the government and corrective action can mitigate damages and demonstrate corporate responsibility, though disclosure does not eliminate liability. The table below outlines key compliance elements that courts and enforcement agencies evaluate:

Before engaging in settlement negotiations or responding to government requests, a corporation should preserve all relevant documents, communications, and records related to the challenged claims. Spoliation of evidence can result in adverse inferences and sanctions. A corporation must also evaluate whether voluntary disclosure to the government is advisable, as disclosure may limit damages exposure but triggers investigation and potential liability. The corporation should document the business rationale for each challenged submission and identify any ambiguities in regulatory interpretation that informed the corporation's submission practices. Timely engagement with experienced counsel helps the corporation navigate the tension between transparency and privilege protection, and ensures that corrective actions are undertaken in a manner that supports rather than undermines the corporation's legal position.